Novel compounds
    1.
    发明申请
    Novel compounds 失效
    新型化合物

    公开(公告)号:US20060135614A1

    公开(公告)日:2006-06-22

    申请号:US10520902

    申请日:2003-07-08

    IPC分类号: A61K31/198 C07C237/28

    CPC分类号: C07C235/52 C07C235/34

    摘要: This invention relates to novel compounds, which are thyroid receptor ligands, and to methods of preparing such compounds. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolism dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described herein is administered in a therapeutically effective amount.

    摘要翻译: 本发明涉及作为甲状腺受体配体的新化合物及其制备方法。 此外,提供了一种用于预防,抑制或治疗与代谢功能障碍相关或与T3调节基因的表达相关的疾病或病症的方法,其中本文所述的化合物以治疗有效量施用。